|
Market Closed -
Nasdaq
16:00:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 84.95 USD | +0.13% |
|
-.--% | +82.49% |
| Market Cap | 9.01B 7.86B 7.42B 6.74B 12.62B 865B 12.67B 88.87B 34.29B 440B 33.85B 33.1B 1,414B | P/E 2024 |
-13.8x | P/E 2025 | -9.41x |
|---|---|---|---|---|---|
| Enterprise Value | 8.03B 7B 6.61B 6B 11.25B 771B 11.3B 79.21B 30.57B 392B 30.17B 29.5B 1,261B | EV / Sales 2024 |
3,310x | EV / Sales 2025 | 447x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CRNX | Delayed | |
CBOE
| CRNX | Real-time | |
|
Tradegate
| 6Z4 | Real-time | |
|
Deutsche Boerse AG
| 6Z4 | Delayed | |
|
Börse Stuttgart
| 6Z4 | Delayed |
Last Transcript: Crinetics Pharmaceuticals
| 1 day | +0.13% | ||
| 1 month | +0.27% | ||
| 3 months | +136.83% | ||
| 6 months | +135.64% | ||
| Current year | +82.49% |
| 1 month | 84.67 |  | 85.01 |
| Current year | 32.3 | | 85.01 |
| 1 year | 32.3 | | 85.01 |
| 3 years | 24.1 | | 85.01 |
| 5 years | 15.23 | | 85.01 |
| 10 years | 10.63 | | 85.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Wagner
PSD | President | 57 | 2026-08-31 |
Omar White
SEC | Corporate Secretary | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Wagner
BRD | Director/Board Member | 57 | 2026-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Issuer sale | Chief Financial Officer | -209,427 | 0.1986% | ||
| 9/1/26 | Issuer sale | Founder | -905,240 | 0.8585% | ||
| 9/1/26 | Issuer sale | Chairman | -232,151 | 0.2202% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.04M 906K 855K 777K 1.46M 99.7M 1.46M 10.25M 3.95M 50.69M 3.9M 3.82M 163M | 7.7M 6.71M 6.34M 5.75M 10.78M 738M 10.83M 75.9M 29.29M 375M 28.91M 28.27M 1.21B |
| Net income | -298M -260M -246M -223M -418M -28.63B -420M -2.94B -1.14B -14.56B -1.12B -1.1B -46.84B | -465M -406M -383M -348M -652M -44.65B -655M -4.59B -1.77B -22.7B -1.75B -1.71B -73.04B |
| Net Debt | -1.3B -1.14B -1.07B -974M -1.82B -125B -1.83B -12.84B -4.96B -63.53B -4.89B -4.78B -204B | -979M -854M -806M -732M -1.37B -93.97B -1.38B -9.66B -3.73B -47.78B -3.68B -3.6B -154B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
